These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3574801)

  • 1. Pregnancy outcomes after first-trimester vaginitis drug therapy.
    Rosa FW; Baum C; Shaw M
    Obstet Gynecol; 1987 May; 69(5):751-5. PubMed ID: 3574801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal drugs and the risk of selected birth defects.
    Carter TC; Druschel CM; Romitti PA; Bell EM; Werler MM; Mitchell AA;
    Am J Obstet Gynecol; 2008 Feb; 198(2):191.e1-7. PubMed ID: 18226621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy.
    Donders GG; Van Calsteren K; Bellen G; Reybrouck R; Van den Bosch T; Riphagen I; Van Lierde S
    BJOG; 2009 Sep; 116(10):1315-24. PubMed ID: 19538417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of cetirizine during pregnancy. A prospective observational cohort study.
    Weber-Schoendorfer C; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
    Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continued occurrence of Accutane-exposed pregnancies.
    Honein MA; Paulozzi LJ; Erickson JD
    Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine.
    Jones KL; Johnson KA; Dick LM; Felix RJ; Kao KK; Chambers CD
    Teratology; 2002 Mar; 65(3):125-30. PubMed ID: 11877776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are blastogenetic anomalies sporadic?
    Martínez-Frías ML; Frías JL
    Am J Med Genet; 1997 Feb; 68(4):381-5. PubMed ID: 9021006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of birth defects associated with nelfinavir exposure during pregnancy.
    Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
    Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivmecillinam and adverse birth and neonatal outcomes: a population-based cohort study.
    Vinther Skriver M; Nørgaard M; Pedersen L; Carl Schønheyder H; Sørensen HT
    Scand J Infect Dis; 2004; 36(10):733-7. PubMed ID: 15513399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of vacuum aspiration abortion on future childbearing: a review.
    Hogue CJ; Cates W; Tietze C
    Fam Plann Perspect; 1983; 15(3):119-26. PubMed ID: 6347709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for legal induced abortion-related mortality in the United States.
    Bartlett LA; Berg CJ; Shulman HB; Zane SB; Green CA; Whitehead S; Atrash HK
    Obstet Gynecol; 2004 Apr; 103(4):729-37. PubMed ID: 15051566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester exposure to alprazolam.
    St Clair SM; Schirmer RG
    Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal antimycotics and the risk for spontaneous abortions.
    Daniel S; Rotem R; Koren G; Lunenfeld E; Levy A
    Am J Obstet Gynecol; 2018 Jun; 218(6):601.e1-601.e7. PubMed ID: 29510088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations.
    Queisser-Luft A; Eggers I; Stolz G; Kieninger-Baum D; Schlaefer K
    Am J Med Genet; 1996 May; 63(1):268-76. PubMed ID: 8723120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
    Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
    Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
    Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcomes after maternal exposure to simvastatin and lovastatin.
    Pollack PS; Shields KE; Burnett DM; Osborne MJ; Cunningham ML; Stepanavage ME
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):888-96. PubMed ID: 16163683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced abortion as a risk factor for subsequent fetal loss.
    Infante-Rivard C; Gauthier R
    Epidemiology; 1996 Sep; 7(5):540-2. PubMed ID: 8862989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.